Navigation Links
Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells
Date:1/24/2008

, is the kind of product the medical industry is looking for."

Derma Sciences obtained the rights to DSC127 via license with the University of Southern California, and has signed a clinical services agreement with U.S. Biotest. The scope of the agreement covers pre-study services, study management, clinical operations, data management and medical writing.

Early testing of DSC127 demonstrated that its healing powers may work by promoting the recruitment of mesenchymal stem cells to sites of tissue injury. Mesenchymal stem cells are integral to the creation of several tissue types including skin, beginning in the fetal stages of development.

DSC127 is a novel angiotensin analog that was shown in various animal models to promote healing and reduce scar formation. As a person ages and gets beyond the age of rapid growth, the number of his or her mesenchymal stem cells greatly diminishes. However, administration of DSC127 at the site of tissue injury may promote the recruitment of mesenchymal stem cells in numbers that support the rapid healing of tissue. Application of DSC127 in various animal models has resulted in the increased pace of angiogenesis, as well as increased keratinocyte and extracellular matrix production, all key drivers for dermal repair.

U.S. Biotest, founded by Drs. Gere diZerega and Kathleen Rodgers, maintains an expertise in the licensed compound and has extensive capability in the development of devices and pharmaceutical agents. Drs. diZerega and Rodgers have previously been involved in the development of 4 medical products that have received FDA approval and 7 medical products that are marketed worldwide. Regarding DSC127, they have directed all pre-clinical work, including compound development, manufacturing validation, toxicology studies, successful National Institutes of Health (NIH) grant submissions, acquisition of an Investigational New Drug (IND), and completion of a Phase I clinical trial.

Regarding Derm
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
2. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
3. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
7. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
8. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ -- The FDA granted traditional approval f...leoside reverse transcriptase inhibitor (NNRTI). I...for use in treatment-experienced adults who are ex...sistant to an NNRTI and other antiretroviral (ARV)...week data from two Phase 3 studies known as DUET-1...
(Date:11/25/2009)...5 /PRNewswire-Asia-FirstCall/ -- China Sky One,Med...y") (Nasdaq: CSKI ), a,leading fully integrated p...r-the-counter drugs in the People,s Republic of Ch...ntly passed the Chinese National Institute for,the... ("ICPBP") examination,for two of its new products...
(Date:11/25/2009)... According to Millennium Research G...logy market intelligence, the nearly $3 billion US...to see rapid growth over the next five years despi... for Trauma Devices 2010 report finds that this...ive years, with competitors introducing specialize...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3This Guys Got Blood and Heart At 320 and Counting Al Fischer Sets Record for Blood Donations 55747 1This Guys Got Blood and Heart At 320 and Counting Al Fischer Sets Record for Blood Donations 55747 2This Guys Got Blood and Heart At 320 and Counting Al Fischer Sets Record for Blood Donations 55747 3This Guys Got Blood and Heart At 320 and Counting Al Fischer Sets Record for Blood Donations 55747 4Edmond Scientific Company Rallies as Certifications 26 Assessments 28C 26A 29 Provider for HIEs Pursuing ARRA ONC Grants 55743 1Edmond Scientific Company Rallies as Certifications 26 Assessments 28C 26A 29 Provider for HIEs Pursuing ARRA ONC Grants 55743 2Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 1Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 2Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 3
...al to Evaluate Safety, Efficacy of Novel Cortisol ...CISCO, Sept. 26 DiObex, Inc., a privately held,bi...therapeutics to treat,metabolic diseases, announce...se 2b clinical trial of DIO-902, a novel cortisol ...t of type 2 diabetes mellitus (T2DM). The Phase 2...
... Details from Phase 1a SAD Clinical Study -, BRIS...ITMN ) announced that the company has begun dosing...ending dose (MAD) clinical trial,evaluating ITMN-1...patitis,C. ITMN-191 is a hepatitis C virus (HCV) p...its partner, Roche. InterMune also reported additi...
Other Medicine Technology:DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 2DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 3InterMune Announces Start of Phase 1b Trial of ITMN-191 2InterMune Announces Start of Phase 1b Trial of ITMN-191 3InterMune Announces Start of Phase 1b Trial of ITMN-191 4
(Date:11/28/2009)...nize signs of depression , , SATURDAY, N...oliday season can trigger melancholy as they think...s or worry about money problems, according to the ... the seasonal blues, the AGS Foundation for Health... and socialize or invite family and friends over. ...
(Date:11/27/2009)...ns Ltd. today issued its latest biochemical analys...the lethality of the virus has dropped from its pe...tbreak in the spring of 2009 to resting non-epidem...fectivity count, however, remains increased. , ...2009 -- Biotech firm Replikins Ltd., which has ana...
(Date:11/27/2009)...re-USNewswire/ -- Preventing disease is the goal o... year, new vaccines are being added to assist in d...ity for the same period of time? And, if not, when...unity strong? ,, In this month,s issue of Ped...diatrics, Michael Pichichero MD, Director of the R...
(Date:11/27/2009)...s announced that it has become a national sponsor ...nprofit organizations dedicated to arthritis resea... Delray Beach, FL (Vocus) November 27, 20...pany specializing in the marketing and retail dist...unced today that is has become a national sponsor ...
(Date:11/27/2009)...PRNewswire/ -- Allrecipes.com , the world,s #1 ...ic numbers, with more than 2.8 million visitors th...re of what was served on the biggest food holiday ... weighed in at 2,225 calories per serving, a 5 per... the Allrecipes site, Sweet Potato Pie I stole t...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4
...sis triggered by the death of over 40 people, who ...h institution's laboratory, has prompted Panamania...ures to resolve a health crisis. Torrijos said...the country's social security system. Medicine...
...sed in the state of Pennsylvania, U.S,reveals that...ns recorded across hospitals there in 2005.// ...l infections of every kind in various hospitals sp...admitted there for some treatment or the other dur...
...rogeny are dependant on a fairly simple factor - A...ough to impact the genes of the future generation/...plements consumed by expectant mice were seen to i...esearchers have long known that there is a connect...
...sts from the Mecca of Fashion, Paris, have uncover...ce of a natural chemical called opiorphin//, a nat...ell known morphine. In their experiments, rod...y prove interesting read, is published in the Proc...
...s have developed a revolutionary vaccine for cance...y and shrink tumors.// The vaccine is expected to ...s shown remarkable results in clinical trials, lea...n given the vaccine the tumor was seen to have dis...
...ts will adhere more closely to their medication re... pharmacy// care program that includes patient edu...cy follow-up, according to a study. The “Fed...ducation Foundation, followed 200 elderly patients...
Other Medicine News:Health News:Hospital infections gaining ground in Pennsylvania hospitals 2Health News:A Vaccine against Cancer 2Health News:Pharmacy Care Program Can Increase Medication Adherence in Elderly 2Health News:Pharmacy Care Program Can Increase Medication Adherence in Elderly 3
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: